Correlation Between TG Therapeutics and Kezar Life
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Kezar Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Kezar Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Kezar Life Sciences, you can compare the effects of market volatilities on TG Therapeutics and Kezar Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Kezar Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Kezar Life.
Diversification Opportunities for TG Therapeutics and Kezar Life
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between TGTX and Kezar is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Kezar Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kezar Life Sciences and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Kezar Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kezar Life Sciences has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Kezar Life go up and down completely randomly.
Pair Corralation between TG Therapeutics and Kezar Life
Given the investment horizon of 90 days TG Therapeutics is expected to generate 0.97 times more return on investment than Kezar Life. However, TG Therapeutics is 1.04 times less risky than Kezar Life. It trades about 0.1 of its potential returns per unit of risk. Kezar Life Sciences is currently generating about -0.04 per unit of risk. If you would invest 1,010 in TG Therapeutics on August 29, 2024 and sell it today you would earn a total of 2,490 from holding TG Therapeutics or generate 246.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
TG Therapeutics vs. Kezar Life Sciences
Performance |
Timeline |
TG Therapeutics |
Kezar Life Sciences |
TG Therapeutics and Kezar Life Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with TG Therapeutics and Kezar Life
The main advantage of trading using opposite TG Therapeutics and Kezar Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Kezar Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will offset losses from the drop in Kezar Life's long position.TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Kezar Life vs. Century Therapeutics | Kezar Life vs. Mineralys Therapeutics, Common | Kezar Life vs. Nkarta Inc | Kezar Life vs. Surrozen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |